Company profile
Trulieve Cannabis Corp.
OTC: TCNNF · Healthcare · Drug Manufacturers - Specialty & Generic
#143 of 1,422 Healthcare companies by revenue40th-percentile growth
EA Score
63CFH 71DQ 56GM 47SS 72
v0.1 · 65/100 weight · provisional
↑ workforce scale, operating margin · ↓ disclosure history, listing tenure
Methodology →Revenue TTM
$1.2B
Rev growth YoY (TTM)
-1.3%
Net income (FY)
-$122.2M
Employees
6,000
as of 2026-08-09
Market cap
$1.6B
as of 2026-08-09
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.2B$1.2B2025
Net income-$122.2M-$122.2M2025
Operating income$143.5M$143.5M2025
Total assets$2.7B$2.7B2025
Liabilities$1.6B$1.6B2025
Equity$1.1B$1.1B2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2024
By product
Retail100%
By geography
Not disclosed.
The read
What is Trulieve Cannabis Corp.’s revenue?
Trulieve Cannabis Corp. booked $1.2B in FY2025 revenue, contracting 0.4% year over year — about the middle of the pack among Healthcare companies we track, at a -10.3% net margin.
Peers · Healthcare
Bio-Techne Corporation85AExtendicare Inc.79B+Omnicell, Inc.78B+Trulieve Cannabis Corp.——Green Thumb Industries Inc.72BSotera Health Company70BKey facts
CEOKimberly Rivers
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
HeadquartersQuincy, FL
ExchangeOTC: TCNNF
Employees6,000
IPO date2018-09-27
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.